New research from the Karolinska Institutet reveals that men with type 2 diabetes and obesity have a higher level of insulin resistance than women. “Our research group has been interested in studying different aspects of insulin resistance in adipose tissue for several years. It is well known that there are sex differences between men and women and the risk of getting type 2 diabetes. However, the underlying mechanisms for the sex difference in risk and the impact of local insulin resistance in adipose tissue is not fully understood.” To learn more about these findings, check out this Medical News Today article: https://hubs.la/Q02Hf_jz0 #DigitalDiagnostics #LumineticsCore #Healthcare #Diabetes
Digital Diagnostics
Medical Equipment Manufacturing
Coralville, Iowa 5,340 followers
AI the Right Way
About us
Digital Diagnostics is a pioneering AI diagnostics company on a mission to transform the quality, accessibility and affordability of healthcare. Founded and led by Dr. Michael Abramoff, an ophthalmologist, neuroscientist and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build autonomous algorithms that make clinical decisions without human intervention. Digital Diagnostics and its flagship product IDx-DR, an autonomous AI system FDA-authorized to diagnose diabetic retinopathy and diabetic macular edema, has proven that intelligent diagnostic platforms can be used safely, efficiently and equitably to improve patient outcomes. As it expands into other diagnostic capabilities, Digital Diagnostics has paved the way for automated diagnosis to become a new standard of care that will contribute significantly to democratizing healthcare. Digital Diagnostics is hiring! Learn more about our featured roles and other open positions here: www.digitaldiagnostics.com/careers/
- Website
-
https://www.digitaldiagnostics.com/
External link for Digital Diagnostics
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Coralville, Iowa
- Type
- Privately Held
- Founded
- 2010
Locations
-
Primary
2300 Oakdale Blvd
Coralville, Iowa 52241, US
Employees at Digital Diagnostics
-
Mark Daly
CTO @ Digital Diagnostics
-
Andrew Felsing
Expert in .NET Development | Passionate about Software Development and Team Empowerment
-
John Bertrand
Chief Executive Officer at Digital Diagnostics | Driver of Healthcare Innovation | Advocate of Value-Based Care | Improving Patient Experience…
-
Katherine Fairchild
Director of Machine Learning and AI
Updates
-
“AI skeptics should assess AI progress by examining niche industry wins, such as Digital Diagnostics’ impact on retinopathy exams. It’s the far-reaching impact of AI that ultimately makes this technology so revolutionary.” A recent article by Osbon Capital Management examines how AI is revolutionizing healthcare and explores its potential to enhance economic productivity and growth. Read more here: https://hubs.ly/Q02H6b6c0 #DigitalDiagnostics #LumineticsCore #AItheRightWay #Healthcare
FDA Approved AI & Inflation - Osbon Capital Management
osboncapital.com
-
Did you know that stress can significantly impact your kidney health? Visit the National Kidney Foundation website to explore how stress can affect your kidneys and discover practical tips to protect your kidney health by managing stress effectively. Find out more here: https://hubs.la/Q02G-fzK0 #DigitalDiagnostics #LumineticsCore #Diabetes #Healthcare
Stress and Your Kidneys
kidney.org
-
We are thrilled to share that Digital Diagnostics has been nominated as one of five 2024 Catalysts Honorees by the Technology Association of Iowa! This is a huge honor, recognizing our dedication to health equity through artificial intelligence. In recognition of our nomination, John Bertrand, our CEO and Co-Founder, will speak at the Catalysts Live event on July 18, at the Willow on Grand in West Des Moines. For more about the event, click here: https://hubs.la/Q02GXW7z0 #DigitalDiagnostics #LumineticsCore #2024Catalysts #DEIinTech
2024 Catalysts Series - Technology Association of Iowa
https://www.technologyiowa.org
-
A study presented at the American Diabetes Association (ADA) 84th Scientific Sessions reveals that fenofibrate, a common cholesterol-lowering drug, may also slow the progression of diabetic retinopathy (DR). “Across the 4-year study period, fenofibrate was associated with a 27% reduction in the progression of DR in patients taking the drug, compared with placebo (22.7% vs. 29.2%).” It's always exciting to hear about promising new treatments that could be paired with early diagnosis to potentially transform the lives of those living with diabetes. Learn more about these findings in this HCPLive article: https://hubs.la/Q02GMyS20 #DigitalDiagnostics #LumineticsCore #ADASciSessions #HealthcareInnovation
Fenofibrate Markedly Lowers Progression of Diabetic Retinopathy
-
How can AI transform healthcare? Hear our Co-Founder and CEO John Bertrand’s thoughts on the subject on the latest episode of the Physician's Weekly podcast, Peer POV: The Pulse on Medicine. Don’t miss this insightful episode! Check it out here: https://lnkd.in/dJqaeNJU #DigitalDiagnostics #LumineticsCore #DigitalHealth #AI
-
We are honored to be included in the Technology Association of Iowa’s 2024 Catalysts Series. This recognition reinforces our commitment to promoting health equity by doing #AItheRightWay. We're also thrilled to share that John Bertrand, Digital Diagnostics’ CEO and Co-Founder, has been invited to speak at the Catalysts Series event, sharing our vision and insights on advancing health equity through innovative AI solutions. #DigitalDiagnostics #LumineticsCore #2024Catalysts #DEIinTech
2024 Catalysts Live: Equity & Accessibility Powered by Technology This year's Catalysts Series showcases five Iowa organizations enabling digital equity and accessibility for employees, customers and communities. Join us on July 18 in West Des Moines to hear the impactful stories of how these organizations are making Iowa more equitable and inclusive through technology: Des Moines Data for Good → From Insight to Impact: Empowering nonprofits to make data-driven decisions and maximize their impact Digital Diagnostics → DEI in Healthcare AI: Working to transform the quality, accessibility, and equity of diagnostic AI in healthcare Iowa Workforce Development - Vocational Rehabilitation Services → Settings For Success: Focusing on a person's abilities and not their disabilities to create impactful solutions in the workplace. Tech Gift Foundation - Kathir Kalyanaraman → Empowering the Underserved through the Gift of Tech: Bridging the digital divide for underserved communities worldwide Wells Enterprises → Breaking Down Language Barriers: Harnessing AI for Document Translation Register Today: https://lnkd.in/gQzYCKef #UniteIowaTech #DEIinTech #2024Catalysts
Register Today for 2024 Catalysts Live on July 18
https://www.technologyiowa.org
-
Thank you to Milibeth Castro from Zufall Health for presenting a Presidents Select abstract about LumineticsCore™ at the American Diabetes Association (ADA) 84th Scientific Sessions in Orlando. Congratulations to Milibeth and Zufall Health Center for positively impacting patient care through the successful integration of LumineticsCore. Check out the award-winning abstract here: https://hubs.la/Q02GcFr20 #DigitalDiagnostics #LumineticsCore #ADASciSessions #Diabetes
-
Researchers in Korea have developed an electronic sock fitted with pressure sensors designed to prevent foot-related complications in people with diabetes. “Identifying walking issues early using an electronic sock would enable patients to learn a healthy walking style and prevent serious foot problems,” said one of the sock’s inventors. We love seeing advancements in technology, particularly those that have the potential to transform the lives of those living with diabetes. Learn more about this revolutionary development here: https://hubs.la/Q02G1rJW0 #DigitalDiagnostics #LumineticsCore #GlobalHealthcare #Diabetes
Electronic socks prevent foot-related complications in diabetic patients - Advanced Science News
-
We’re thrilled to share that Digital Diagnostics’ Founder and Executive Chairman, Michael D. Abramoff, MD, PhD, will be a featured speaker at the Annual Focus on Eye Health Summit, a FREE virtual event hosted by Prevent Blindness. Join Dr. Abramoff on July 11, 2024, at 1:15 PM, for a roundtable discussion exploring opportunities and considerations of AI in eyecare. For more information, visit: https://hubs.la/Q02FVlml0 #EyeSummit #DigitalDiagnostics #LumineticsCore #AI